Heart re-transplantation in Eurotransplant
- PMID: 29885002
- DOI: 10.1111/tri.13289
Heart re-transplantation in Eurotransplant
Abstract
Internationally 3% of the donor hearts are distributed to re-transplant patients. In Eurotransplant, only patients with a primary graft dysfunction (PGD) within 1 week after heart transplantation (HTX) are indicated for high urgency listing. The aim of this study is to provide evidence for the discussion on whether these patients should still be allocated with priority. All consecutive HTX performed in the period 1981-2015 were included. Multivariate Cox' model was built including: donor and recipient age and gender, ischaemia time, recipient diagnose, urgency status and era. The study population included 18 490 HTX, of these 463 (2.6%) were repeat transplants. The major indications for re-HTX were cardiac allograft vasculopathy (CAV) (50%), PGD (26%) and acute rejection (21%). In a multivariate model, compared with first HTX hazards ratio and 95% confidence interval for repeat HTX were 2.27 (1.83-2.82) for PGD, 2.24 (1.76-2.85) for acute rejection and 1.22 (1.00-1.48) for CAV (P < 0.0001). Outcome after cardiac re-HTX strongly depends on the indication for re-HTX with acceptable outcomes for CAV. In contrast, just 47.5% of all hearts transplanted in patients who were re-transplanted for PGD still functioned at 1-month post-transplant. Alternative options like VA-ECMO should be first offered before opting for acute re-transplantation.
Keywords: complications; heart clinical; outcome; rejection.
© 2018 The Authors. Transplant International published by John Wiley & Sons Ltd on behalf of Steunstichting ESOT.
Similar articles
-
Outcomes of third heart transplants in pediatric and young adult patients: analysis of the United Network for Organ Sharing database.J Heart Lung Transplant. 2014 Sep;33(9):917-23. doi: 10.1016/j.healun.2014.04.009. Epub 2014 Apr 19. J Heart Lung Transplant. 2014. PMID: 24861821
-
Heart transplantation: 25 years' single-centre experience.J Cardiovasc Med (Hagerstown). 2013 Sep;14(9):637-47. doi: 10.2459/JCM.0b013e32835dbd74. J Cardiovasc Med (Hagerstown). 2013. PMID: 23340045
-
Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.J Heart Lung Transplant. 2015 Aug;34(8):1112-9. doi: 10.1016/j.healun.2015.03.015. Epub 2015 Mar 26. J Heart Lung Transplant. 2015. PMID: 25940077
-
Early Graft Dysfunction Following Heart Transplant: Prevention and Management.Semin Cardiothorac Vasc Anesth. 2020 Mar;24(1):24-33. doi: 10.1177/1089253219867694. Epub 2019 Aug 5. Semin Cardiothorac Vasc Anesth. 2020. PMID: 31378136 Review.
-
European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):919-48. doi: 10.1093/ehjci/jev139. Epub 2015 Jul 2. Eur Heart J Cardiovasc Imaging. 2015. PMID: 26139361 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous